SCHEMBL1310330

SCHEMBL1310330

O=C1OC=CC1=CNCc1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 5/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
THRB P10828 2/20 0.35
ALOX12 P18054 2/20 0.35
HIF1A Q16665 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
GFER P55789 1/20 0.33
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310502 0.86 ALDH1A1 (0.48) SMN1; SMN2LMNAKMT2AALDH1A1L3MBTL1
SCHEMBL1310957 0.85 KMT2A (0.38) SMN1; SMN2LMNAKMT2AALDH1A1L3MBTL1
SCHEMBL1310266 0.81 ALDH1A1 (0.52) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL1311374 0.76 MAPT (0.45) SMN1; SMN2LMNAKMT2AALDH1A1L3MBTL1
SCHEMBL14972766 0.75 CYP1A2 (0.46) LMNAALDH1A1L3MBTL1MAPTKDM4E
SCHEMBL1325767 0.69 ADH1B (0.34) ADH1BADH1AADH7
SCHEMBL5221625 0.67 ADH1B (0.61) KMT2AALDH1A1L3MBTL1MEN1MAPT
SCHEMBL15107290 0.59 CA2 (0.43) KMT2AALDH1A1L3MBTL1MEN1MAPT
SCHEMBL6277988 0.59 CA2 (0.61) LMNAKMT2AALDH1A1L3MBTL1MEN1
SCHEMBL2359652 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846125-B2 Enaminocarbonyl compounds and their use INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2014-09-30 US disclosed
EP-2391614-B1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INST CHEMII ORGANICZNEJ POLSKA AKADEMIA NAUK (PL) 2013-05-29 EP disclosed
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE TAS2R42, TAS2R41, TAS2R1 SMN1; SMN2 991/4885LMNA 814/4885KMT2A 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.